pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    afatinib dimaleate
    Gilotrif (afatinib dimaleate)
    Non-Small Cell Lung Cancer Boehringer Ingelheim Corp
  • Phase 2
    afimetoran
    afimetoran
    Systemic Lupus Erythematosus Beeline Medicines Corp
  • Phase 3
    afimkibart
    afimkibart
    Crohn's Disease (Regional Enteritis) F. Hoffmann-La Roche Ltd
  • Phase 3
← prev
page 181 of 271
next →
Pain89
Neurology1
afuresertib hydrochloride
afuresertib hydrochloride
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Laekna Inc
  • Marketed
    agalsidase beta
    Fabrazyme (agalsidase beta)
    Fabry Disease Genzyme Corp
  • Phase 3
    aglatimagene besadenovec
    ProstAtak (aglatimagene besadenovec)
    Prostate Cancer$CADL Candel Therapeutics, Inc.
  • Phase 2
    agomelatine
    agomelatine [INN]
    Major Depressive Disorder$ANRO Alto Neuroscience, Inc.
  • Phase 2
    aguracingene cadoparvovec
    aguracingene cadoparvovec
    Achromatopsia$MGTX MeiraGTx Holdings plc
  • Marketed
    albendazole
    Albendazole
    Echinococcosis (Hydatid Disease) Novadoz Pharmaceuticals LLC
  • Marketed
    albumin (human)
    Human Albumin (albumin (human))
    Hypovolemia (Hypovolaemia) Octapharma USA Inc
  • Phase 3
    albumin (recombinant) (human)
    Hypoalbuminemia Wuhan Healthgen Biotechnology Corp
  • Marketed
    albutrepenonacog alfa LA
    Idelvion (albutrepenonacog alfa [INN])
    Hemophilia B (Factor IX Deficiency) CSL Behring LLC
  • Phase 2
    albuvirtide LA
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Frontier Biotechnologies Inc
  • Marketed
    alcaftadine
    Alcaftadine
    Allergic Conjunctivitis Fosun Pharma USA Inc
  • Marketed
    alclometasone dipropionate
    Alclometasone Dipropionate
    Atopic Dermatitis (Atopic Eczema) Fougera Pharmaceuticals Inc
  • Marketed
    aldesleukin
    Proleukin (aldesleukin)
    Metastatic Renal Cell Carcinoma$IOVA IOVANCE BIOTHERAPEUTICS, INC.
  • Phase 3
    aldoxorubicin
    aldoxorubicin
    Metastatic Pancreatic Cancer LadRx Corp
  • Marketed
    alectinib
    Alecensa (alectinib)
    Non-Small Cell Lung Cancer F. Hoffmann-La Roche Ltd
  • Marketed
    alemtuzumab
    Campath (alemtuzumab)
    B-Cell Chronic Lymphocytic Leukemia Genzyme Corp
  • Phase 2
    aleniglipron l-arginine
    aleniglipron l-arginine
    Overweight$GPCR Structure Therapeutics Inc.
  • Marketed
    alfuzosin hydrochloride ER
    Uroxatral (alfuzosin hydrochloride)
    Storage Symptoms of Benign Prostatic Hyperplasia Concordia Healthcare USA Inc
  • Preclinical
    alidornase alfa
    alidornase alfa [INN]
    Pulmonary Sarcoidosis Sarcomed AB
  • Phase 2
    alintegimod
    alintegimod [INN]
    Colorectal Cancer 7 Hills Pharma LLC
  • Phase 2
    alisertib
    alisertib
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$PBYI PUMA BIOTECHNOLOGY, INC.
  • Marketed
    aliskiren fumarate
    Aliskiren Fumarate Prasco (aliskiren fumarate)
    Hypertension Prasco LLC
  • Phase 3
    alixorexton
    alixorexton
    Type 1 Narcolepsy (Narcolepsy with Cataplexy)$ALKS Alkermes plc.
  • Phase 3
    allantoin
    Zorblisa (allantoin)
    Epidermolysis Bullosa Paradigm Therapeutics Inc
  • Marketed
    allopurinol
    Zyloprim (allopurinol)
    Kidney Disease (Nephropathy) Casper Pharma LLC
  • Marketed
    almotriptan malate
    Almotriptan (almotriptan malate)
    Migraine Ajanta Pharma USA Inc
  • Phase 2
    alnodesertib
    alnodesertib [INN]
    Metastatic Colorectal Cancer Artios Pharma Ltd